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Enhancing patient satisfaction with adiabetes disease management program(DDMP) raises the quality of care (1),
controls costs, enhances outcomes (2,3),
and thereby reduces patient attrition (4).
Currently, there is no existing comprehen-
sive tool that will capture patient satisfaction
with the essential components of a DDMP.
The purpose of this article is to describe the
development of a tool designed to assess
patient satisfaction with a DDMP that can
be used for any diabetes population.
The use of DDMPs to control the com-
plications of diabetes and the ensuing costs
(estimated to exceed $100 billion annually
in the U.S. [5]) that accrue when diabetes is
undiagnosed, untreated, or uncontrolled is
becoming more frequent (6,7). However,
despite the 10 million cases diagnosed in
the U.S. (8) and the high associated costs,
DDMPs are still evolving.
The American Diabetes Association
(ADA) annually publishes their standards
of medical care for patients with diabetes
(9), and these standards serve as the basis
for many DDMPs. However, these are stan-
dards for care and not standards for
DDMPs. For these reasons, an operational
definition is difficult to create. For this
study, a definition of DDMPs was adopted
from the literature and operationalized as “a
systematic, population-based approach to
identify persons at risk, intervene with spe-
cific programs of care, and measure clinical
and other outcomes” (10).
In addition, the patient population and
the curriculum directly shape the definition
of DDMPs. Trends seen in local DDMPs sug-
gest that most enrollees are newly diagnosed
or are in the early stages of the disease.
Because there are common aspects of care
across types of diabetes, all diabetes types
were considered for questionnaire design.
The cornerstone of current DDMPs is
patient education based on the ADA’s rec-
ommended standards (9). Education is also
a key element leading to behavioral change
through patient empowerment supported
by the social learning theory (11). In addi-
tion, the Diabetes Control and Complica-
tions Trial (DCCT) established that educa-
tion is critical to maintaining normal blood
glucose ranges in patients with type 1 dia-
betes, which delays the onset of complica-
tions due to diabetes (12). Although no sim-
ilar trial has been completed in people with
type 2 diabetes, other studies have provided
enough evidence to conclude that the results
of the DCCT can reasonably apply to people
with type 2 diabetes (8,13,14).
A review of the literature was conducted
to investigate additional tools to measure
satisfaction with diabetes care (Table 1).
Although available instruments have unique
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Development and Validation of a
Questionnaire to Evaluate Patient
Satisfaction With Diabetes Disease
Management
O R I G I N A L  A R T I C L E
OBJECTIVE — To develop a reliable and valid questionnaire to measure patient satisfaction
with diabetes disease management programs.
RESEARCH DESIGN AND METHODS — Questions related to structure, process, and
outcomes were categorized into 14 domains defining the essential elements of diabetes disease
management. Health professionals confirmed the content validity. Face validity was established
by a patient focus group. The questionnaire was mailed to 711 patients with diabetes who par-
ticipated in a disease management program.
To reduce the number of questionnaire items, a principal components analysis was per-
formed using a varimax rotation. The Scree test was used to select significant components. To
further assess reliability and validity, Cronbach’s  and product-moment correlations were cal-
culated for components having 3 items with loadings 0.50.
RESULTS — The validated 73-item mailed satisfaction survey had a 34.1% response rate. Prin-
cipal components analysis yielded 13 components with eigenvalues 1.0. The Scree test proposed
a 6-component solution (39 items), which explained 59% of the total variation. Internal consis-
tency reliabilities computed for the first 6 components ( = 0.79–0.95) were acceptable.
CONCLUSIONS — The final questionnaire, the Diabetes Management Evaluation Tool
(DMET), was designed to assess patient satisfaction with diabetes disease management pro-
grams. Although more extensive testing of the questionnaire is appropriate, preliminary reli-
ability and validity of the DMET has been demonstrated.
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strengths, no instrument includes a broad
array of items measuring satisfaction with
DDMPs. The Diabetes Treatment Satisfaction
Questionnaire (DTSQ) (15) has been used
most often to measure satisfaction with dia-
betes care. Even though this brief 8-item
questionnaire provides important informa-
tion about selected aspects of traditional dia-
betes treatment, it was not designed to cover
the breadth of DDMPs that were nascent
when the DTSQ was developed. Most
importantly, the DTSQ does not assess the
patients’ satisfaction with their ability to con-
trol their diabetes, and it doesn’t include the
self-care components of diabetes control,
such as nutrition and physical activity (9).
A new tool that elicits satisfaction with
a DDMP would be beneficial to health pro-
fessionals as DDMPs have become the stan-
dard for improving diabetes outcomes.
Furthermore, a tool modeling the theoret-
ical framework of Donabedian (16), which
emphasizes structure, process, and out-
come, will best capture the dynamics of
DDMPs that are essential for measuring
patient satisfaction.
Questionnaire development
Stage 1: Item generation. To prepare a
comprehensive set of items measuring the
most important aspects of DDMPs, an
expert panel of health care professionals
identified the 14 following domains of
patient satisfaction that are important for
successful DDMPs: physical activity, nutri-
tion, glucose monitoring, program ameni-
ties, staff, meetings, information taught,
acute complications, severe complications,
time commitment, convenience, general
program, follow-up, and treatment. As
directed by the expert panel and reinforced
by the current literature on the management
of diabetes, 3 of these 14 domains of disease
management (nutrition, physical activity,
and glucose monitoring) were evaluated in
depth. These 3 components are the foun-
dation for managing all types of diabetes
(17–19) and are essential to managing
patients with type 2 diabetes who may not
rely on insulin to control glucose (18,19).
Given the emerging emphasis on
patient-centered experiences advocated by
the Agency for Healthcare Research and
Quality and the Picker Institute (20),
items were added to elicit satisfaction with
the patients’ understanding of their con-
dition, their personal influence over their
treatment plans, and the likelihood of
behavior modification.
Each domain was populated with items
by using the overlying themes of structure,
process, and outcomes, as described by
Donabedian (21,22). This theoretical frame-
work was used to capture how the structure
of a DDMP affects patient satisfaction, how
patients perceive their experiences navigat-
ing through the delivery of care, and how
the process affects the patient’s health.
Stage 2: Validation. To assess content
validity, diabetes care professionals from
the Jefferson Health System (Philadelphia,
PA) reviewed the questionnaire to ensure
relevance and clarity of the items. Two
expert panels totaling 25 individuals that
included certified diabetes educators,
nurses, pharmacists, and physicians were
formed. Feedback from the expert panels
clarified appropriate use of terminology,
such as “physical activity” instead of “exer-
cise.” Suggested additions included ques-
tions about weight management, counsel-
ing, medicinal effects, and the effect
nutrition and physical activity have on glu-
cose levels. The expert panels confirmed
that all of the areas pertinent to the man-
agement of diabetes were sampled.
A patient focus group was conducted
to establish the face validity of the ques-
tionnaire. A DDMP run by the family prac-
tice group at Thomas Jefferson University
Hospital was used to obtain participants
for the focus group. At the completion of
this 6-week program, a list of patients who
attended at least 2 meetings was used to
make random phone calls for recruitment.
Acquiring patients in this manner was
Table 1—Published studies between 1987 and 1997 based on questionnaires used to assess different aspects of diabetes
Study investigator(s)
(reference) Survey name Description
Anderson et al. (39) Diabetes Attitude Scale A 50-item diabetes-related questionnaire that measures the patients’ attitudes toward the 
need for special training, patient compliance, seriousness of type 2 diabetes, glucose 
control and complications, impact of diabetes on patients’ lives, patient autonomy
and team care.
Bradley (15) Diabetes Treatment Satisfaction The 8-item questionnaire captures satisfaction with treatment and understanding of diabetes. 
Questionnaire (DTSQ) It also measures frequency of acceptable blood sugars, convenience, and flexibility.
Bradley and Lewis (40) Treatment Satisfaction and The treatment satisfaction segment of the instrument consisted of 11 questions that 
Psychological Well-being assess a patient’s satisfaction with their recent treatment.
Day et al. (41) The Ipswich Diabetes The 41-item questionnaire relates to the patients’ attitudes toward and influence on actual 
Self-Management Questionnaire self-management behavior, blood testing routine, and estimates of diabetic control.
Davis et al. (42) Diabetes Educational Profile The 110-item survey examined the relationship of patients’ psychosocial adjustment to 
(DEP) disease type, treatment mode, and indexes of control.
Fitzgerald et al. (43) Diabetes Care Profile The 234-item instrument measures social and psychological factors related to diabetes and 
its treatment.
Diabetes Control and Diabetes Quality of Life (DQOL) The questionnaire was designed to assess diabetes treatment regimens on the appearance 
Complications Trial and progression of early vascular complications. However, the DQOL may also be useful
(DCCT) Research in evaluating the quality of life in other groups of patients with type 1 diabetes.
Group (12)
American Hospital Picker Patient Satisfaction The survey elicits specific reports from patients about the aspects of care they perceived  
Association and the Survey as important.
Picker Institute (20)
important in gaining a sample representa-
tive of all levels of satisfaction, by includ-
ing patients that may have dropped out of
the program.
Feedback from the focus groups con-
sisted of patients identifying ambiguous
items and suggesting additional items.
Items were reworded to eliminate ambigu-
ous phrasing. For instance, the word “diet”
was replaced with “what you can eat”; “glu-
cose” was replaced with “blood sugar”;
“counseling” was replaced with “the help
you received”; and “referrals” was replaced
with “getting help in scheduling appoint-
ments.” New items included references to
advertising the program, program supplies,
prejudice against people with diabetes,
wound healing, and the effects of depres-
sion, weight gain, stress, sexual function,
and blood pressure on glucose levels. Issues
that were addressed more extensively were
fear of diabetes, availability of support
groups, and maintaining a diet plan. This
step established face validity by having a
sample of respondents verify that all areas
intended to be measured by the question-
naire really were (23). Combined with the
content validity of the provider focus
group, the face validity of the patient focus
group addressed all the variants of patient
satisfaction that are relevant to disease man-
agement.
Stage 3: Questionnaire finalization. The
final questionnaire consisted of 87 items
organized in 3 sections. The first section
(73 items) referred to the patients’ satisfac-
tion with services provided by the DDMP,
satisfaction with their understanding of
diabetes, and their ability to use the infor-
mation they learned. Satisfaction was mea-
sured using 71 randomly ordered items
with Likert scale responses (1 = very dis-
satisfied, 2 = slightly dissatisfied, 3 = nei-
ther satisfied nor dissatisfied, 4 = slightly
satisfied, and 5 = very satisfied). This Likert
scale was chosen because it has been used
commonly in patient satisfaction question-
naires (3,24) and is therefore familiar to
patients. Two additional items in this sec-
tion required yes-or-no responses. The sec-
ond section (8 items) captured behavioral
change as a result of the DDMP using the
following Likert scale responses: 1 = very
unlikely, 2 = slightly unlikely, 3 = neither
likely nor unlikely, 4 = slightly likely, and
5 = very likely. The final section (6 items)
measured global satisfaction as a compari-
son for statistical analyses and also used a
Likert scale with responses ranging from
“very dissatisfied” to “very satisfied.” For
the Likert-scaled items, each response scale
was preceded with the sixth option of “does
not apply.”
RESEARCH DESIGN AND 
METHODS — The study sample
included 711 patients who either completed
a diabetes program at the Jefferson Family
Medicine Diabetes Program, Frankford Hos-
pital between 1993 and 1998 or other Jef-
ferson Health System ( JHS) patients
identified with diabetes. Subjects received a
demographics survey, the satisfaction ques-
tionnaire, a short-form 36 quality-of-life
questionnaire (25), a description of the
incentive (glucose monitor), and a definition
of DDMPs. Nonrespondents were contacted
to encourage a response.
Data analysis
Respondents were included in the analysis
if all 3 surveys were completed, severe
complications were not reported, and at
least 90% of the questions on the satisfac-
tion questionnaire were completed. This
action was taken because if 10% of the
questions did not apply, it was assumed
that the subject had not participated in a
program that met criteria for a DDMP
(7,10). Questions were deleted from the
analysis when the option “does not apply”
was chosen by 15% of all of the respon-
dents. For all of the remaining items, a
response of “does not apply” was recoded
as “neither satisfied nor dissatisfied.”
To determine if there were empirically
derivable subscales and to reduce the num-
ber of questionnaire items, a principal com-
ponents analysis was performed. Prior
communality estimates of one were used to
verify that each variable was given one full
unit of variance to be factored in the origi-
nal correlation matrix. The criterion of
Kaiser (26) was used to retain the individual
items (23) with eigenvalues 1.0.
The retained component structure
was rotated using varimax rotation
methods. Component loadings of 0.50
were considered significant and were
retained for the final questionnaire.
These components were subjected to the
Scree test (23,27), which determined
which of the components would be most
meaningful for measuring patient satis-
faction with a DDMP.
Cronbach’s  (23,28) estimated the
internal consistency reliability of compo-
nents with eigenvalues 1.0 that also
included 3 items with weights 0.50 in
the rotated component-loading matrix.
Product-moment correlations were
computed between component satisfaction
scores and the 6 items measuring global
satisfaction to assess construct validity.
RESULTS
Patient demographics
A total of 242 of 711 patients returned the
questionnaires. Of these, 23 were not ana-
lyzed because 10% of the items were
checked as “does not apply” and an addi-
tional 17 did not meet the inclusion crite-
ria. Table 2 reports demographics for the
202 analyzed questionnaires.
Of the 3 questionnaire sections (patient
satisfaction, behavioral change, and global
satisfaction), the behavioral change ques-
tions consistently demonstrated low corre-
lations and were excluded from the final
analysis. These patterns suggest that behav-
ior change is not positively associated with
patient satisfaction. The 6 global satisfac-
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Table 2—Demographics of patients respond-
ing to the mailout questionnaire (n = 202)
Age (years)
Mean 55.7
Range 3–98
65 (n [%]) 58 (28.9)
Total responses 201
Sex (n [%])
M 79 (39.7)
F 120 (60.3)
Diabetes type (n [%])
Type 1 24 (12.1)
Type 2 172 (86.9)
Gestational 2 (1.0)
Diabetes duration (years)
Mean ± SD 8.8 ± 13.6
6 months (n [%]) 60 (31.9)
Total responses 188
Insured (n [%]) 199 (97.4)
Enroller of patient (n [%])
Doctor 115 (67.7)
Health insurer 7 (4.1)
Other 48 (28.2)
Short-form 36 scores (averages)
Physical function 69
Role physical 56
Pain 62
General health 56
Vitality 51
Social function 72
Role emotion 64
Mental health 69
Data are n, unless otherwise indicated.
tion scores were used in the analysis as
comparison items.
Of the 73 patient satisfaction items, 13
were dropped from the multivariate analy-
sis because 15% of patients checked the
“does not apply” option. These questions
targeted parking, equipment, handicap
accessibility, availability of meetings, public
transportation, support groups, sexual
activity, prejudices, advertising, and pro-
gram length. Sixty satisfaction items were
used in the final analyses.
Although most of the remaining 60
patient satisfaction items showed mean sat-
isfaction scores above 4.5, there was
enough variation to justify their inclusion
in the multivariate analysis. Frequency dis-
tributions were analyzed to ensure that
floor-ceiling effects did not cause the mean
satisfaction score to be abnormally high.
Acquiescence (24) and social desirability
(29) did not appear to have an effect. The
logical components produced would not
otherwise be seen if response-set bias was
an issue.
Principal components analysis
Kaiser’s criterion (eigenvalue = 1.0) (26) was
used to enter the 60 items into the analysis,
and 13 components were extracted. A vari-
max rotation was performed to distribute the
total variance explained by the 13 compo-
nents more evenly.
An examination of the Scree plot (27)
of the eigenvalues of the 13 components
demonstrated a curve that had several plau-
sible breaks where a meaningful solution
could be retained. A 6-component solution
suggested by the Scree plot adequately rep-
resented the data in a meaningful way. The
6-component solution was accepted
because it didn’t eliminate too many items
in this preliminary analysis and because it
ensured that several different dimensions of
DDMPs were still captured.
The 6 components explain 59% of the
variation in satisfaction, and each include
3 items (Table 3). The components that
were eliminated included availability of
information, travel time, meeting topics,
frequency of abnormal glucose levels, coun-
seling, staff’s helpfulness and knowledge,
understanding of blood sugar monitors,
recipes, fear, confidence, and check-ups.
Table 3 contains items defining each
component along with their varimax com-
ponent loadings for the component on
which the item loads most highly. The final
set of items included several aspects of the
essential areas of DDMP (nutrition, physical
activity, and glucose monitoring) as defined
by the provider focus groups. Four ques-
tions address physical activity by asking
about the patient’s understanding with the
types and amount of physical activity neces-
sary to control diabetes, general satisfaction
with the types of physical activity taught,
and satisfaction with the support received to
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Table 3—The 6-component solution and the component loadings for the items defining each
component
Component loadings
Component and item labels I II III IV V VI
Factor I: meetings*
Q11: Helpful staff .53 .09 .21 .08 .05 .11
Q22: Ease of scheduling a time .60 .08 .19 .16 .21 .02
Q13: Discuss your type of diabetes .61 .20 .13 .17 .18 .13
Q30: Ease of reaching schedule person .61 .06 .04 .06 .17 .38
Q15: Availability of refreshments .65 .20 .06 .01 .23 .04
Q16: Convenience of location .66 .07 .02 .19 .05 .01
Q25: Safety .66 .01 .02 .09 .03 .28
Q39: Staff treats you with respect .67 .04 .19 .20 .07 .14
Q21: Useful information .68 .08 .26 .04 .00 .11
Q19: Interesting discussion topics .68 .17 .19 .01 .13 .29
Q29: Pleasantness of schedule person .71 .04 .20 .09 .04 .13
Q05: Information program gave you .72 .15 .18 .15 .14 .09
Q41: Ease of finding .75 .12 .02 .10 .04 .13
Q51: Cleanliness .76 .11 .01 .14 .08 .04
Q03: Begin on time .77 .01 .20 .04 .11 .05
Q04: Topics are always different .78 .22 .07 .00 .05 .04
Q54: Speakers are interesting .79 .19 .11 .02 .00 .18
Q14: Last the right amount of time .80 .07 .09 .16 .24 .04
Factor II: understanding general complications†
Q52: Sexual organs .08 .50 .32 .30 .21 .08
Q64: Things you can and can’t do .22 .55 .10 .23 .16 .12
Q68: Depression .20 .72 .24 .01 .26 .14
Q58: Blood pressure .14 .74 .05 .34 .01 .05
Q59: Stress .15 .79 .18 .22 .09 .12
Q60: Weight gain .09 .81 .15 .07 .07 .16
Factor III: personal nutrition‡
Q31: When to check blood sugar levels .22 .28 .50 .12 .13 .18
Q57: How to deal with diabetes .20 .38 .51 .16 .20 .18
Q56: What to eat for control .18 .15 .53 .43 .31 .12
Q61: Food labels .06 .32 .66 .24 .18 .15
Q23: What you can and can’t eat .20 .28 .68 .23 .23 .15
Factor IV: personal physical activity§
Q06: Physical activity for diabetes control .27 .19 .40 .55 .22 .13
Q53: Help for planning physical activity .08 .37 .24 .65 .24 .03
Q43: Amount of physical activity needed .15 .23 .23 .68 .10 .38
Q50: Types of physical activity .11 .30 .12 .78 .16 .11
Factor V: personal time commitment
Q33: Flexibility of food plan .10 .23 .33 .04 .64 .09
Q07: Amount of time spent watching what you eat for control .08 .11 .19 .25 .73 .01
Q08: Amount of time spent getting checkups .06 .15 .08 .11 .79 .28
Factor VI: understanding severe complications¶
Q32: Unexpected problems .15 .29 .27 .05 .15 .54
Q09: Diabetes emergency .26 .13 .15 .12 .26 .67
Q42: Eye care .23 .22 .14 .33 .05 .68
* Reliability = 0.95, variance explained = 38.2%, and eigenvalue = 22.9; † reliability = 0.88, variance
explained = 9.1%, and eigenvalue = 5.5; ‡ reliability = 0.87, variance explained = 3.4%, and eigenvalue = 2.0;
§ reliability = 0.87, variance explained = 3.0%, and eigenvalue = 1.8;  reliability = 0.79, variance
explained = 2.6%, and eigenvalue = 1.5; ¶ reliability = 0.78, variance explained = 2.4%, and eigenvalue = 1.5.
plan types of physical activity. Nutrition was
encompassed by 5 questions asking satis-
faction with: the amount of time spent and
flexibility of watching what you eat to con-
trol diabetes, understanding what to eat to
control diabetes, the help received to make
a food plan, and how to follow food labels to
control diabetes. Glucose monitoring was
assessed by 4 questions that asked satisfac-
tion with understanding of when to check
blood sugar levels and understanding of
how blood pressure, stress, and depression
affects blood sugar levels.
Reliability
Internal consistency reliabilities were com-
puted for the 6 components. Table 3 dis-
plays the  values (scale reliability
coefficients) ranging from 0.79 to 0.95. As
expected for scores computed from scale
items grouped by principal components
criteria, the observed reliabilities are accept-
able (23) at this stage in research and even
highly significant for the 6 components.
Validity
The product-moment correlations between
the component satisfaction scores and the 6
global items dealing with overall patient
satisfaction suggest strong relationships,
confirming construct validity. Overall pro-
gram satisfaction was most highly corre-
lated (0.71) with meetings (component I),
as expected from the literature (30,31). The
patients’ satisfaction with their under-
standing of nutrition (component III) had a
moderately positive correlation (r = 0.41–
0.54), reflecting an increased satisfaction
with all aspects of the program as satisfac-
tion with their understanding of nutrition
increased. The correlation score between
component V (time commitment) and
overall program demonstrated a weak pos-
itive correlation (0.28), which indicated
that as satisfaction with time commitment
decreased, satisfaction with the overall pro-
gram decreased as well.
CONCLUSIONS — This brief ques-
tionnaire, the Diabetes Measurement and
Evaluation Tool (DMET), was developed to
assess patient satisfaction with the struc-
ture, process, and outcomes of compre-
hensive DDMPs.
The most important and distinctive fea-
ture of the DMET is that it assesses the
patients’ satisfaction with a DDMP. Whereas
other patient satisfaction surveys measure
selected aspects of diabetes care, no other
survey includes an array of items that cov-
ers all of the components encompassed by
a DDMP. In addition to their satisfaction
with their understanding of diabetes-related
complications, the DMET assesses patients’
satisfaction with the structure and process
of meetings, personal time commitment,
the level of physical activity, and their per-
sonal nutrition requirements needed to
maintain their health.
A second strength is that it addresses
patient satisfaction with outcomes in addi-
tion to the traditional evaluation of the struc-
ture and process of health care delivery (1).
There is increasing recognition of the need to
use patient satisfaction in outcome surveys.
This need has been shown in a study under-
taken by the Picker Institute and the Amer-
ican Hospital Association, which found that
the patient satisfaction reported on ques-
tionnaires was consistently higher than the
level of satisfaction reported by patients in
focus groups and patient interviews (20).
Therefore, the DMET was designed to assess
time, costs, and traits, as suggested by Ross
et al. (32); the structure, process, and out-
comes according to Donabedian (16,33);
and comprehensive care across the contin-
uum, as defined by Press (34).
This initial study of the instrument has
several limitations. The response rate of 33%
is comparable with other mailed patient sat-
isfaction questionnaires (35), and it is ade-
quate for this study. Although the sample
size of 202 patients would be inadequate for
a definitive principal components analysis
(23), it is noteworthy that in this exploratory
stage, the component structure condensed
the 14 domains into 6 representative valid
components. Nevertheless, the respondents’
experiences and motivations for participa-
tion possibly differ from those of the nonre-
sponder. Additionally, this sample was
limited to one health system and may there-
fore represent a limited sample of the popu-
lation of patients with diabetes. Further
testing of the DMET in a variety of diabetes
populations, especially type 1 diabetic pop-
ulations, will confirm the validity and relia-
bility of the questionnaire.
It is worth noting that two-thirds of the
respondents were registered for a DDMP by
their physician, whereas 5% were
referred by their health insurer. As Jonsson
(36) noted: “The costs for control of dia-
betes constitute less than 25% of the total
costs of diabetes. Improvements in the con-
trol of diabetes have the potential to reduce
direct costs for treatment of complications
as well as indirect costs. Improvements in
the treatment of complications can reduce
the indirect costs.” This conclusion was
reiterated in more recent articles (37). The
advancements made by organizations such
as the Pennsylvania Health Care Contain-
ment Council (38), which includes dia-
betes control benchmarks in quality
improvement activities, could be enhanced
if insurers would encourage the use of
DDMPs for all of their patients to control
diabetes-related costs.
In conclusion, the DMET was found to
be reliable and valid for the assessment of
patient satisfaction with DDMPs. As with
all questionnaires, continuous testing and
refinement is necessary.
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